PortfoliosLab logoPortfoliosLab logo
NOAH vs. CORT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NOAH vs. CORT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Noah Holdings Limited (NOAH) and Corcept Therapeutics Incorporated (CORT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NOAH achieves a -9.76% return, which is significantly lower than CORT's 228.99% return. Over the past 10 years, NOAH has underperformed CORT with an annualized return of -6.61%, while CORT has yielded a comparatively higher 35.35% annualized return.


NOAH

1D
-0.47%
1M
-9.67%
6M
-23.61%
YTD
-9.76%
1Y
-23.67%
3Y*
-5.53%
5Y*
-19.65%
10Y*
-6.61%
ALL TIME*
-0.75%

CORT

1D
-3.24%
1M
26.91%
6M
187.16%
YTD
228.99%
1Y
65.93%
3Y*
66.06%
5Y*
40.69%
10Y*
35.35%
ALL TIME*
10.54%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$163.77M$133.02M$94.73M
$721.39K$869.80K$803.46K

NOAH vs. CORT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NOAH
Noah Holdings Limited
-9.76%-5.58%6.83%-8.37%-49.49%-35.81%35.17%-18.35%-6.40%111.04%
CORT
Corcept Therapeutics Incorporated
228.99%-30.94%55.14%59.92%2.58%-24.31%116.20%-9.43%-26.02%148.76%

Correlation

The correlation between NOAH and CORT is 0.19, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.19

Correlation (3Y)
Balances recent behavior with more history.

0.17

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.20

Correlation (10Y)
Provides a long-term view across more market conditions.

0.20

Correlation (All Time)
Calculated using the full available price history since Nov 10, 2010

0.20

Fundamentals

Market Cap

NOAH:

$564.02M

CORT:

$12.29B

EPS

NOAH:

CN¥38.08

CORT:

$0.48

PE Ratio

NOAH:

1.50

CORT:

240.95

PS Ratio

NOAH:

0.31

CORT:

15.92

PB Ratio

NOAH:

0.08

CORT:

19.20

Total Revenue (TTM)

NOAH:

CN¥2.61B

CORT:

$830.81M

Gross Profit (TTM)

NOAH:

CN¥2.07B

CORT:

$816.73M

EBITDA (TTM)

NOAH:

CN¥683.80M

CORT:

$23.30M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NOAH vs. CORT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

NOAH
NOAH Risk / Return Rank: 99
Overall Rank
NOAH Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
NOAH Sortino Ratio Rank: 1313
Sortino Ratio Rank
NOAH Omega Ratio Rank: 1313
Omega Ratio Rank
NOAH Calmar Ratio Rank: 77
Calmar Ratio Rank
NOAH Martin Ratio Rank: 22
Martin Ratio Rank

CORT
CORT Risk / Return Rank: 7272
Overall Rank
CORT Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
CORT Sortino Ratio Rank: 7070
Sortino Ratio Rank
CORT Omega Ratio Rank: 8686
Omega Ratio Rank
CORT Calmar Ratio Rank: 6868
Calmar Ratio Rank
CORT Martin Ratio Rank: 6565
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

NOAH vs. CORT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Noah Holdings Limited (NOAH) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NOAHCORTDifference
Sharpe ratioReturn per unit of total volatility

-1.65

Sortino ratioReturn per unit of downside risk

-2.46

Omega ratioGain probability vs. loss probability

0.87

1.31

-0.44

Calmar ratioReturn relative to maximum drawdown

-0.92

1.10

-2.02

Martin ratioReturn relative to average drawdown

-1.75

2.01

-3.76

NOAH vs. CORT - Sharpe Ratio Comparison

The current NOAH Sharpe Ratio is -0.79, which is lower than the CORT Sharpe Ratio of 0.86. The chart below compares the historical Sharpe Ratios of NOAH and CORT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NOAH vs. CORT - Drawdown Comparison

The maximum NOAH drawdown since its inception was -86.16%, smaller than the maximum CORT drawdown of -94.29%. Use the drawdown chart below to compare losses from any high point for NOAH and CORT.


Loading charts...

Drawdown Indicators


NOAHCORTDifference

Max Drawdown

Largest peak-to-trough decline

-86.16%

-94.29%

+8.13%

Max Drawdown (1Y)

Largest decline over 1 year

-27.81%

-64.40%

+36.59%

Max Drawdown (3Y)

Largest decline over 3 years

-44.80%

-71.85%

+27.05%

Max Drawdown (5Y)

Largest decline over 5 years

-80.36%

-71.85%

-8.51%

Max Drawdown (10Y)

Largest decline over 10 years

-86.16%

-71.85%

-14.31%

Current Drawdown

Current decline from peak

-80.88%

-3.24%

-77.64%

Average Drawdown

Average peak-to-trough decline

-49.19%

-53.26%

+4.07%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.55%

35.24%

-20.69%

Volatility

NOAH vs. CORT - Volatility Comparison

The current volatility for Noah Holdings Limited (NOAH) is 9.05%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 28.47%. This indicates that NOAH experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NOAHCORTDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.05%

28.47%

-19.42%

Volatility (6M)

Calculated over the trailing 6-month period

23.17%

48.65%

-25.48%

Volatility (1Y)

Calculated over the trailing 1-year period

32.46%

82.04%

-49.58%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

54.66%

75.77%

-21.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

50.53%

67.83%

-17.30%

Dividends

NOAH vs. CORT - Dividend Comparison

NOAH's dividend yield for the trailing twelve months is around 8.17%, while CORT has not paid dividends to shareholders.


PositionTTM202520242023
CORT
Corcept Therapeutics Incorporated
0.00%0.00%0.00%0.00%
NOAH
Noah Holdings Limited
8.17%11.53%18.15%2.90%

Financials

NOAH vs. CORT - Financials Comparison

This section allows you to compare key financial metrics between Noah Holdings Limited and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

NOAH vs. CORT - Profitability Comparison

The chart below illustrates the profitability comparison between Noah Holdings Limited and Corcept Therapeutics Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

NOAH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Noah Holdings Limited reported a gross profit of 523.29M and revenue of 625.75M. Therefore, the gross margin over that period was 83.6%.

CORT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Corcept Therapeutics Incorporated reported a gross profit of 252.09M and revenue of 256.15M. Therefore, the gross margin over that period was 98.4%.

NOAH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Noah Holdings Limited reported an operating income of 236.44M and revenue of 625.75M, resulting in an operating margin of 37.8%.

CORT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Corcept Therapeutics Incorporated reported an operating income of 41.30M and revenue of 256.15M, resulting in an operating margin of 16.1%.

NOAH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Noah Holdings Limited reported a net income of 124.72M and revenue of 625.75M, resulting in a net margin of 19.9%.

CORT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Corcept Therapeutics Incorporated reported a net income of 42.14M and revenue of 256.15M, resulting in a net margin of 16.5%.


Frequently Asked Questions


NOAH and CORT have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CORT has higher volatility (28.47%) compared to NOAH (9.05%). In terms of maximum drawdown, NOAH dropped -86.16% vs CORT's -94.29%.

CORT currently has the higher Sharpe Ratio (0.86 vs -0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NOAH and CORT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer